Beverly System, a Better Choice for Brewers from Hamilton Company
October 29, 2013
Developed in collaboration with brewers, Hamilton Company, a leader in process analytics, announces the launch of Beverly, a portable dissolved oxygen (DO) measurement system. The Beverly system combines Hamilton’s best-in-class VisiFerm™ DO B optical DO sensor and intelligent Arc™ microprocessor in a rugged casing for accurate, economical DO measurement throughout brewing operations, from fermentation, filtration, [...]
HEPREGEN LAUNCHES FIRST MONKEY HEPATOPACTM ASSAY KITS AT ANNUAL USER GROUP MEETING
October 29, 2013
CAMBRIDGE, MASS.-- Today, at the Company's annual User Group Meeting, Hepregen Corporation, leader in the development of next generation HepatoPacTM and HepatoMuneTM cell-based assay products, announced the commercial launch of the Company's first application-oriented, monkey HepatoPacTM kits, designed specifically for use in metabolite identification and profiling. The kits contain one or more standard 24-well tissue [...]
Smiths Detection’s new handheld explosives identifier improves responder safety
October 29, 2013
Edgewood, Md. – Smiths Detection today introduces ACE-ID, an advanced, handheld chemical identifier that has been rigorously tested to ensure its safe use when analyzing suspected explosives. It also identifies toxic industrial chemicals (TICs) and narcotics. In 20 seconds or less, ACE-ID allows explosive ordnance division (EOD) teams, bomb squads, HazMat technicians, and law enforcement [...]
Enzo Biochem and Sequenom partner to Market key laboratories prenatal testing service
October 29, 2013
NEW YORK -- The Enzo Clinical Labs subsidiary of Enzo Biochem, Inc. (NYSE:ENZ) has entered into an agreement to market in its northeast U.S. service area a proprietary early non-invasive prenatal laboratory test (“LDT”) service, MaterniT21 PLUS ™, developed by the Sequenom Laboratories, Inc., subsidiary of Sequenom, Inc. (NASDAQ:SQNM). “The addition of Sequenom Laboratories’ innovative [...]
October 28, 2013
ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT: BTX) today announced changes to the organization and management of its research products business. The research products business will be consolidated into a new ESI BIO Division which shall be BioTime’s primary developer, manufacturer and distributor for its growing portfolio of stem-cell-based research products. Jeffrey Janus, BioTime’s Vice [...]
October 28, 2013
SAN DIEGO & VANCOUVER, British Columbia -- Sophiris Bio Inc. (NASDAQ: SPHS) (TSX: SHS) today announced that enrollment has begun and the first patients have been dosed in a Phase 3 trial of PRX302 (topsalysin) as a treatment for lower urinary tract symptoms of benign prostatic hyperplasia (BPH or enlarged prostate). The Phase 3 international, [...]
Life Technologies’ Ion AmpliSeq” Exome Certified Service Provider Program Adds European Members
October 28, 2013
GLASGOW, Scotland -- Life Technologies Corporation (NASDAQ: LIFE) today announces four new members in Europe to its Ion AmpliSeq™ Exome Certified Service Provider program, an organization of some of the world's top service providers that sequence and analyze human exomes. Using the Ion AmpliSeq™ Exome Kit, the Ion Proton™ Sequencer, and the Ion Reporter™ Software, [...]
PeloBiotech to Distribute ReachBio’s Products in Germany, Austria and Switzerland
October 28, 2013
Seattle, WA -- ReachBio LLC (Seattle, WA, USA) announced today that it has signed an agreement with PeloBiotech GmbH (Munich, Germany) giving PeloBiotech exclusive distribution rights to ReachBio’s full product line for the life science research market within Germany, Austria and Switzerland. ReachBio provides research products and contract services for applications in basic life science [...]
Definiens Expands Management Team to Develop the Clinical Market
October 28, 2013
Today Definiens, the global leader in image analysis for digital pathology and diagnostics, announced the next step in its strategic roadmap for driving the clinical market for image analysis. Augmenting the earlier hiring of Ralf Huss as Chief Medical Officer, Definiens has added key business team members, Pablo Jordan and Rebecca Berghorn. “All experts point [...]
October 28, 2013
FRANKLIN LAKES, NJ – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, together with Direct Relief and the National Association of Community Health Centers (NACHC), today launched BD Helping Build Healthy CommunitiesSM, a four-year initiative that will expand access and improve care for underserved and vulnerable populations in the U.S. The [...]
